First-Trimester itraconazole exposure and pregnancy outcome: A prospective cohort study of women contacting teratology information services in Italy

Drug Safety

Volumn 32, Issue 3, 2009, Pages 239-244

  De Santis, Marco ^a,c   Di Gianantonio, Elena ^b   Cesari, Elena ^a   Ambrosini, Guido ^b   Straface, Gianluca ^a   Clementi, Maurizio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c L Go Gemelli 8   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ADULT; ARTICLE; BRAIN CALCIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL DISEASE; HEART ATRIUM SEPTUM DEFECT; HEPATOMEGALY; HUMAN; HYDRONEPHROSIS; INDUCED ABORTION; ITALY; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SPONTANEOUS ABORTION; VAGINAL DELIVERY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIFUNGAL AGENTS; BIRTH WEIGHT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INFORMATION SERVICES; FEMALE; HUMANS; ITALY; ITRACONAZOLE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

EID: 63849315580     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200932030-00006     Document Type: Article

References (20)

1. Gupta AK, Tomas E. New antifungal agents. Dermatol Clin 2003; 21 (3): 565-76
2. Tiboni GM, Giampietro F. Murine teratology of fluconazole: evaluation of development phase specificity and dose dependance. Pediatr Res 2005; 58 (1): 94-9
3. Van Cauteren H, Lampo A, Vandenberghe J, et al. Safety aspects of oral antifungal agents. Br J Clin Pract Symp Suppl 1990; 71: 47-9
4. Tiboni GM, Gianpietro F, Del Corso A. Cleft palate and limb defects induced by a single high dose of itraconazole. Reprod Toxicol 2005; 20: 485
5. Bar-Oz B, Moretti ME, Bissai R, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obst Gynecol 2000; 183: 617-20
6. Sporanox® (itraconazole) injection [online]. Available from URL: http://www.fda.gov/cder/foi/label/1999/20966lbl.pdf [Accessed 2008 Dec 29]
7. Schaefer C, Hanneman D, Meister R. Post marketing surveillance system for drugs in pregnancy: 15 years experience of ENTIS. Reprod Toxicol 2005; 20: 331-43
8. Clementi M, Di Gianantonio E, Ornoy A. Teratology information services in Europe and their contribution to the prevention of congenital anomalies. Community Genet 2002; 5: 8-12
9. Tiboni GM, Marotta F, Del Corso A, et al. Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Toxicol Lett 2006; 167: 8-18
10. Reprotox® [online]. Available from URL: http://www.reprotox.org/ Members/AgentDetails.aspx?a=2676 [Accessed 2008 Dec 29]
11. Menegola E, Broccia ML, Di Renzo F, et al. Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects. Reprod Toxicol 2006; 22: 186-95
12. Rosa F. Azole fungicide pregnancy risks. Ninth International Conference of Teratology Information Service; 1996 May 2-4; Salt Lake City (UT)
13. Chotmongkol V, Sookprasert A. Itraconazole in cryptococcal meningitis in pregnancy: a case report. JMed Assoc Thai 1992; 75: 606-8
14. Wilton LV, Pearce GL, Martin RM, et al. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 1998; 105: 882-9
15. Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999; 19: 221-2
16. Bar Oz B, Moretti ME, Mareels G. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999; 354: 1700-1
17. Brent RL. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 2004; 113: 957-68
18. Geyman JP, Oliver LM, Sullivan SD. Expectant, medical, or surgical treatment of spontaneous abortion in the first trimester of pregnancy? A pooled quantitative literature evaluation. J Am board Fam Pract 1999; 12: 55-64
19. De Santis M, Cavaliere AF, Straface G, et al. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fertil Steril 2005; 84: 296-9
20. Schaefer C, OrnoyA, Clementi M, et al. Using observational cohort data for studying drug effects on pregnancy outcome: methodological considerations. Repr Toxicol 2008; 26: 36-41